Serum unsaturated free fatty acids: A potential biomarker panel for early-stage detection of colorectal cancer

Journal of Cancer

Volumn 7, Issue 4, 2016, Pages 477-483

  Zhang, Yaping ^a   He, Chengyan ^b   Qiu, Ling ^c   Wang, Yanmin ^d   Qin, Xuzhen ^c   Liu, Yujie ^a   Li, Zhili ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b JILIN UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^d Heze Municipal Hospital   (China)

Author keywords

Biomarker panel; Colorectal cancer; Early detection; Serum; Unsaturated free fatty acids

Indexed keywords

UNSATURATED FATTY ACID;

ADULT; ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 84971539130     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.13870     Document Type: Article

References (33)

1. Wang F, Wang FH, Bai L, Xu RH. Role of capecitabine in treating metastatic colorectal cancer in Chinese patients. Onco Targets Ther 2014, 7: 501-511.
2. Labianca R, Beretta GD, Mosconi S, Milesi L, Pessi MA. Colorectal cancer: screening. Ann Oncol 2005, 16 Suppl 2: ii127-132.
3. Mahabaleshwarkar R, Khanna R, West-Strum D, Yang Y. Association Between Health-Related Quality of Life and Colorectal Cancer Screening. Popul Health Manag 2013, 16: 178-189.
4. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev 2011, 33: 88-100.
5. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterol 2008, 134: 1570-1595.
6. Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM. A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer Detection. Am J Gastroenterol 2008, 103: 2862-2870.
7. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of Fecal Immunochemical Tests for Colorectal Cancer Systematic Review and Meta-analysis. Ann Intern Med 2014, 160: 171-181.
8. Seyfried TN, Flores RE, Poff AM, D'Agostino DP. Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis 2014, 35: 515-527.
9. Tan B, Qiu Y, Zou X, Chen T, Xie G, Cheng Y, Dong T, Zhao L, Feng B, Hu X, Xu LX, Zhao A, Zhang M, Cai G, Cai S, Zhou Z, Zheng M, Zhang Y, Jia W. Metabonomics identifies serum metabolite markers of colorectal cancer. J Proteome Res 2013, 12: 3000-3009.
10. Williams MD, Reeves R, Resar LS, Hill HH. Metabolomics of colorectal cancer: past and current analytical platforms. Anal Bioanal Chem 2013, 405: 5013-5030.
11. Santos CR, Schulze A. Lipid metabolism in cancer. Febs J 2012, 279: 2610-2623.
12. Huang Q, Tan Y, Yin P, Ye G, Gao P, Lu X, Wang H, Xu G. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res 2013, 73: 4992-5002.
13. Serini S, Piccioni E, Merendino N, Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis 2009, 14: 135-152.
14. Zhang YP, Qiu L, Wang YM, Qin X, Li ZL. High-throughput and high-sensitivity quantitative analysis of serum unsaturated fatty acids by chip-based nanoelectrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry: early stage diagnostic biomarkers of pancreatic cancer. Analyst 2014, 139: 1697-1706.
15. Zhang YP, Song LN, Liu N, He CY, Li ZL. Decreased serum levels of free fatty acids are associated with breast cancer. Clin Chim Acta 2014, 437: 31-37.
16. Zhang YP, He CY, Qiu L, Wang YM, Zhang L, Qin XZ, Liu YJ, Zhang D, Li ZL. Serum Unsaturated Free Fatty Acids: Potential Biomarkers for Early Detection and Disease Progression Monitoring of Non-Small Cell Lung Cancer. Journal of Cancer 2014, 5: 706-714.
17. Zhang YP, Qiu L, Wang YM, He CY, Qin XZ, Liu YJ, Li ZL. Unsaturated free fatty acids: a potential biomarker panel for early detection of gastric cancer. Biomarkers 2014, 19: 667-673.
18. Szachowicz-Petelska B, Sulkowski S, Figaszewski ZA. Altered membrane free unsaturated fatty acid composition in human colorectal cancer tissue. Mol Cell Biochem 2007, 294: 237-242.
19. Wang H, Tso VK, Slupsky CM, Fedorak RN. Metabolomics and detection of colorectal cancer in humans: a systematic review. Future Oncol 2010, 6: 1395-1406.
20. Kondo Y, Nishiumi S, Shinohara M, Hatano N, Ikeda A, Yoshie T, Kobayashi T, Shiomi Y, Irino Y, Takenawa T, Azuma T, Yoshida M. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry. Biomarkers in Medicine 2011, 5: 451-460.
21. Zhang J, Zhang L, Ye X, Chen L, Gao Y, Kang JX, Cai C. Characteristics of fatty acid distribution is associated with colorectal cancer prognosis. Prostaglandins Leukot Essent Fatty Acids 2013, 88: 355-360.
22. Ruiz-Vela A, Aguilar-Gallardo C, Martinez-Arroyo AM, Soriano-Navarro M, Ruiz V, Simon C. Specific unsaturated fatty acids enforce the transdifferentiation of human cancer cells toward adipocyte-like cells. Stem Cell Rev 2011, 7: 898-909.
23. Giros A, Grzybowski M, Sohn VR, Pons E, Fernandez-Morales J, Xicola RM, Sethi P, Grzybowski J, Goel A, Boland CR, Gassull MA, Llor X. Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic. Cancer Prev Res (Phila) 2009, 2: 732-742.
24. Tjonneland A, Overvad K, Bergmann MM, Nagel G, Linseisen J, Hallmans G, Palmqvist R, Sjodin H, Hagglund G, Berglund G, Lindgren S, Grip O, Palli D, Day NE, Khaw KT, Bingham S, Riboli E, Kennedy H, Hart A. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009, 58: 1606-1611.
25. Murff HJ, Shu XO, Li H, Dai Q, Kallianpur A, Yang G, Cai H, Wen W, Gao YT, Zheng W. A prospective study of dietary polyunsaturated fatty acids and colorectal cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 2009, 18: 2283-2291.
26. Tokudome S, Kojima M, Suzuki S, Ichikawa H, Ichikawa Y, Miyata M, Maeda K, Marumoto M, Agawa H, Arakawa K, Tanaka T, Ando R, Hattori N, Goto C, Tokudome Y, Imaeda N, Kuriki K, Okuyama H, Moore MA. Marine n-3 fatty acids and colorectal cancer: is there a real link? Cancer Epidemiol Biomarkers Prev 2006, 15: 406-407.
27. Kuriki K, Wakai K, Hirose K, Matsuo K, Ito H, Suzuki T, Saito T, Kanemitsu Y, Hirai T, Kato T, Tatematsu M, Tajima K. Risk of colorectal cancer is linked to erythrocyte compositions of fatty acids as biomarkers for dietary intakes of fish, fat, and fatty acids. Cancer Epidemiol Biomarkers Prev 2006, 15: 1791-1798.
28. Key TJ, Appleby PN, Masset G, Brunner EJ, Cade JE, Greenwood DC, Stephen AM, Kuh D, Bhaniani A, Powell N, Khaw KT. Vitamins, minerals, essential fatty acids and colorectal cancer risk in the United Kingdom Dietary Cohort Consortium. Int J Cancer 2012, 131: E320-325.
29. Li F, Qin XZ, Chen HQ, Qiu L, Guo YM, Liu H, Chen GQ, Song GG, Wang XD, Li FJ, Guo S, Wang BH, Li ZL. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commu Mass Spectrom 2013, 27: 24-34.
30. Nishiumi S, Kobayashi T, Ikeda A, Yoshie T, Kibi M, Izumi Y, Okuno T, Hayashi N, Kawano S, Takenawa T, Azuma T, Yoshida M. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One 2012, 7: e40459.
31. Tagi T, Matsui T, Kikuchi S, Hoshi S, Ochiai T, Kokuba Y, Kinoshita-Ida Y, Kisumi-Hayashi F, Morimoto K, Imai T, Imoto I, Inazawa J, Otsuji E. Dermokine as a novel biomarker for early-stage colorectal cancer. J Gastroenterol 2010, 45: 1201-1211.
32. Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, Ofner A, Crispin A, Neumann J, Lamerz R, Kolligs FT. Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer. Am J Gastroenterol 2011, 106: 1110-1118.
33. Liu M, Li CF, Chen HS, Lin LQ, Zhang CP, Zhao JL, Liu Y, Zhang SJ, Jin JC, Wang L, Liu JR. Differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy controls. Proteome Sci 2010, 8: 16.